Skip to main content

Peer Review reports

From: Effectiveness of traditional non-carbapenem β-lactams vs. novel β-lactams for the treatment of carbapenem-resistant Pseudomonas aeruginosa: a retrospective cohort study

Original Submission
2 Sep 2024 Submitted Original manuscript
4 Sep 2024 Author responded Author comments - Namareq F. Aldardeer
4 Sep 2024 Author responded Author comments - Namareq F. Aldardeer
Resubmission - Version 2
4 Sep 2024 Submitted Manuscript version 2
5 Sep 2024 Author responded Author comments - Namareq F. Aldardeer
Resubmission - Version 3
5 Sep 2024 Submitted Manuscript version 3
8 Sep 2024 Author responded Author comments - Namareq F. Aldardeer
Resubmission - Version 4
8 Sep 2024 Submitted Manuscript version 4
14 Sep 2024 Author responded Author comments - Namareq F. Aldardeer
Resubmission - Version 5
14 Sep 2024 Submitted Manuscript version 5
14 Nov 2024 Reviewed Reviewer Report
21 Nov 2024 Reviewed Reviewer Report
28 Nov 2024 Reviewed Reviewer Report
12 Dec 2024 Author responded Author comments - Namareq F. Aldardeer
Resubmission - Version 6
12 Dec 2024 Submitted Manuscript version 6
Publishing
17 Dec 2024 Editorially accepted
22 Dec 2024 Article published 10.1186/s12879-024-10365-5

You can find further information about peer review here.

Back to article page